Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 334 participants.

Also called NCT05132920

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 334 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05132920
  • EudraCT 2021-000732-54
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05132920. Randomized; quadruple masking; primary purpose treatment. Start 2021-12-03 (actual); primary completion 2024-09-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage
Acronym
FINISHER
Condition
Aneurysmal Subarachnoid Hemorrhage
Intervention (Drug)
Dexamethasone
Intervention (Drug)
Placebo
Lead sponsor
University Hospital, Bonn (class: other)
Collaborator
German Federal Ministry of Education and Research (class: other government)
Collaborator
Pharmacy of the University Hospital Leipzig- AöR (class: not stated)
Collaborator
nextevidence GmbH (class: not stated)

Record details

Record id
cardio:ct-nct05132920
Content hash
4a253bf60f34de5f098b5d3558b0593587624bdae2cd26b3e4193231a6923577